Latest round: Growth. Scott Kellen is the Chief Financial Officer of DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on vascular.
Scott Kellen is the Chief Financial Officer of DiaMedica Therapeutics, a clinical-stage biopharmaceutical company focused on vascular diseases. He serves as the primary contact for investor relations at the Minneapolis-based firm, managing communications and financial disclosures.
Full founder directory · Investor directory · Company funding database · Fundraising library